Skip to main content

Advertisement

Log in

Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Gastric-type adenocarcinoma (GA) is an aggressive subtype of cancer of the uterine cervix. Several immunohistochemical markers for gastric mucins, such as mucin 6 (MUC6) and N-acetylglucosamine α1 → 4galactose → R (αGlcNAc-R), which is recognized by HIK1083 antibody, have been introduced for diagnosis of GA and lobular endocervical glandular hyperplasia (LEGH). However, MUC6 is also expressed in normal endocervical glands and HIK1083 antibody has limited availability. Trefoil factor family 2 protein (TFF2) is secreted by gastric, but not normal endocervical glands. Here, we evaluated TFF2 immunostaining for detection of a gastric immunophenotype in endocervical glandular lesions. We compared TFF2, αGlcNAc-R, and MUC6 expression in 103 endocervical glandular lesions: LEGH (n = 23), adenocarcinoma in situ/microinvasive adenocarcinoma (AIS–MIA) (n = 29), and invasive adenocarcinoma (usual type [UA], n = 26; GA, n = 11; intestinal type [IA], n = 2; signet ring cell type [Sig], n = 2; and mucinous adenocarcinoma not otherwise specified [NOS], n = 10). TFF2 and αGlcNAc-R expression was completely concordant in each subtype: LEGH (100%), AIS–MIA (44.8%), UA (26.9%), GA (90.9%), IA (100%), Sig (0%), and NOS (20%). TFF2 staining scores were significantly correlated with those of αGlcNAc-R in these lesions. TFF2 and αGlcNAc-R immunoreactivity was present in cytoplasmic mucins and luminal secretions. TFF2 and αGlcNAc-R were not expressed in the normal endocervical glands. MUC6 was frequently expressed in normal endocervical glands and endocervical glandular lesions. Endocervical adenocarcinomas sometimes stained only for MUC6. TFF2 is a promising immunohistochemical marker and its identification in uterine cervical secretion is a potentially useful diagnostic test for endocervical glandular lesions with gastric differentiation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Smith HO, Tiffany MF, Qualls CR, Key CR (2000) The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States - a 24-year population-based study. Gynecol Oncol 78(2):97–105. https://doi.org/10.1006/gyno.2000.5826

    Article  CAS  PubMed  Google Scholar 

  2. Wilbur DC, Colgan TJ, Ferenczy AS, Hirchowiz L, Loening T, McCluggage WG, Mikami Y, Park KJ, Ronnett BM, Schneider A, Soslow R, Wells M, Wright T (2014) Glandular tumours and precursors. In: Kurman RJ, Carcangiu ML, Herrington CS, Young RH (eds) WHO classification of tumours of female reproductive organs. Internat. Agency for Research on Cancer, Lyon, pp 183–189

    Google Scholar 

  3. Kojima A, Mikami Y, Sudo T, Yamaguchi S, Kusanagi Y, Ito M, Nishimura R (2007) Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol 31(5):664–672. https://doi.org/10.1097/01.pas.0000213434.91868.b0

    Article  PubMed  Google Scholar 

  4. Kusanagi Y, Kojima A, Mikami Y, Kiyokawa T, Sudo T, Yamaguchi S, Nishimura R (2010) Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype. Am J Pathol 177(5):2169–2175. https://doi.org/10.2353/ajpath.2010.100323

    Article  PubMed  PubMed Central  Google Scholar 

  5. Karamurzin YS, Kiyokawa T, Parkash V, Jotwani AR, Patel P, Pike MC, Soslow RA, Park KJ (2015) Gastric-type endocervical adenocarcinoma. An aggressive tumor with unusual metastatic patterns and poor prognosis. Am J Surg Pathol 39(11):1449–1457. https://doi.org/10.1097/PAS.0000000000000532

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ishii K, Hosaka N, Toki T, Momose M, Hidaka E, Tsuchiya S, Katsuyama T (1998) A new view of the so-called adenoma malignum of the uterine cervix. Virchows Arch 432(4):315–322

    Article  CAS  PubMed  Google Scholar 

  7. Nucci MR, Clement PB, Young RH (1999) Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum. Am J Surg Pathol 23(8):886–891. https://doi.org/10.1016/j.ygyno.2011.05.006

    Article  CAS  PubMed  Google Scholar 

  8. Mikami Y, Kyokawa T, Hata S, Fujiwara K, Moriya T, Sasano H, Manabe T, Akahira JI, Ito K, Tase T, Yaegashi N, Sato I, Tateno H, Naganuma H (2004) Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and ‘adenoma malignum’. Mod Pathol 17(8):962–972. https://doi.org/10.1038/modpathol.3800148

    Article  PubMed  Google Scholar 

  9. Kondo T, Hashi A, Murata S, Nakazawa T, Yuminamochi T, Nara M, Hoshi K, Katoh R (2005) Endocervical adenocarcinomas associated with lobular endocervical glandular hyperplasia: a report of four cases with histochemical and immunohistochemical analyses. Mod Pathol 18(9):1199–1210. https://doi.org/10.1038/modpathol.3800403

    Article  CAS  PubMed  Google Scholar 

  10. Nara M, Hashi A, Murata S-I, Kondo T, Yuminamochi T, Nakazawa K, Katoh R, Hoshi K (2007) Lobular endocervical glandular hyperplasia as a presumed precursor of cervical adenocarcinoma independent of human papillomavirus infection. Gynecol Oncol 106(2):289–298. https://doi.org/10.1016/j.ygyno.2007.03.044

    Article  PubMed  Google Scholar 

  11. Kawauchi S, Kusuda T, Liu XP, Suehiro Y, Kaku T, Mikami Y, Takeshita M, Nakao M, Chochi Y, Sasaki K (2008) Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma? A comparative molecular-genetic and immunohistochemical study. Am J Surg Pathol 32(12):1807–1815. https://doi.org/10.1097/PAS.0b013e3181883722

    Article  PubMed  Google Scholar 

  12. Liao SY, Rodgers WH, Kauderer J, Darcy KM, Carter R, Susumu N, Nagao S, Walker JL, Hatae M, Stanbridge EJ (2013) Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study. Br J Cancer 108(3):613–620. https://doi.org/10.1038/bjc.2012.578

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Mikami Y, Minamiguchi S, Teramoto N, Nagura M, Haga H, Konishi I (2013) Carbonic anhydrase type IX expression in lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix. Pathol Res Pract 209(3):173–178. https://doi.org/10.1016/j.prp.2012.12.003

    Article  CAS  PubMed  Google Scholar 

  14. Talia KL, Stewart CJ, Howitt BE, Nucci MR, McCluggage WG (2017) HPV-negative gastric type adenocarcinoma in situ of the cervix: a spectrum of rare lesions exhibiting gastric and intestinal differentiation. Am J Surg Pathol 41(8):1023–1033. https://doi.org/10.1097/PAS.0000000000000855

    Article  PubMed  Google Scholar 

  15. Ishihara K, Kurihara M, Goso Y, Urata T, Ota H, Katsuyama T, Hotta K (1996) Peripheral alpha-linked N-acetylglucosamine on the carbohydrate moiety of mucin derived from mammalian gastric gland mucous cells: epitope recognized by a newly characterized monoclonal antibody. Biochem J 318:409–416

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Utsugi K, Hirai Y, Takeshima N, Akiyama F, Sakurai S, Hasumi K (1999) Utility of the monoclonal antibody HIK1083 in the diagnosis of adenoma malignum of the uterine cervix. Gynecol Oncol 75(3):345–348. https://doi.org/10.1006/gyno.1999.5622

    Article  CAS  PubMed  Google Scholar 

  17. Ota H, Harada O, Uehara T, Hayama M, Ishii K (2011) Aberrant expression of TFF1, TFF2, and PDX1 and their diagnostic value in lobular endocervical glandular hyperplasia. Am J Clin Pathol 135(2):253–261. https://doi.org/10.1309/ajcpqmao3pw4ogof

    Article  PubMed  Google Scholar 

  18. Yamanoi K, Ishii K, Tsukamoto M, Asaka S, Nakayama J (2018) Gastric gland mucin-specific O-glycan expression decreases as tumor cells progress from lobular endocervical gland hyperplasia to cervical mucinous carcinoma, gastric type. Virchows Arch 473(3):305–311. https://doi.org/10.1007/s00428-018-2381-6

    Article  CAS  PubMed  Google Scholar 

  19. Maeda D (2015) Utility of claudin-18 and p16 immunohistochemistry for distinguishing gastric-type adenocarcinoma from other subtypes of cervical adenocarcinoma. Mod Pathol 28:296A–297A

    Google Scholar 

  20. Maeda D (2016) Expression of claudin-18, a novel gastric marker, is associated with poor prognosis in cervical adenocarcinoma. Mod Pathol 29:296A–296A

    Google Scholar 

  21. Pastorekova S, Parkkila S, Parkkila AK, Opavsky R, Zelnik V, Saarnio J, Pastorek J (1997) Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. Gastroenterology 112(2):398–408

    Article  CAS  PubMed  Google Scholar 

  22. Tafreshi NK, Lloyd MC, Bui MM, Gillies RJ, Morse DL (2014) Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases. Subcell Biochem 75:221–254. https://doi.org/10.1007/978-94-007-7359-2_12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Kende AI, Carr NJ, Sobin LH (2003) Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract. Histopathology 42(2):137–140

    Article  CAS  PubMed  Google Scholar 

  24. Weikel W, Wagner R, Moll R (1987) Characterization of subcolumnar reserve cells and other epithelia of human uterine cervix. Demonstration of diverse cytokeratin polypeptides in reserve cells. Virchows Arch B Cell Pathol Incl Mol Pathol 54(2):98–110

    Article  CAS  PubMed  Google Scholar 

  25. Ota H, Hayama M, Nakayama J, Hidaka H, Honda T, Ishii K, Fukushima M, Uehara T, Kurihara M, Ishihara K, Hotta K, Katsuyama T (2001) Cell lineage specificity of newly raised monoclonal antibodies against gastric mucins in normal, metaplastic, and neoplastic human tissues and their application to pathology diagnosis. Am J Clin Pathol 115(1):69–79. https://doi.org/10.1309/AMUR-K5L3-M2DN-2DK5

    Article  CAS  PubMed  Google Scholar 

  26. Nakajima K, Ota H, Zhang MX, Sano K, Honda T, Ishii K, Nakayama J (2003) Expression of gastric gland mucous cell-type mucin in normal and neoplastic human tissues. J Histochem Cytochem 51(12):1689–1698. https://doi.org/10.1177/002215540305101213

    Article  CAS  PubMed  Google Scholar 

  27. Zhang MX, Nakayama J, Hidaka E, Kubota S, Yan J, Ota H, Fukuda M (2001) Immunohistochemical demonstration of alpha1,4-N-acetylglucosaminyltransferase that forms GlcNAcalpha1,4Galbeta residues in human gastrointestinal mucosa. J Histochem Cytochem 49(5):587–596. https://doi.org/10.1177/002215540104900505

    Article  CAS  PubMed  Google Scholar 

  28. Bartman AE, Buisine MP, Aubert JP, Niehans GA, Toribara NW, Kim YS, Kelly EJ, Crabtree JE, Ho SB (1998) The MUC6 secretory mucin gene ts expressed in a wide variety of epithelial tissues. J Pathol 186(4):398–405. https://doi.org/10.1002/(SICI)1096-9896(199812)186:4<398::AID-PATH192>3.0.CO;2-X

    Article  CAS  PubMed  Google Scholar 

  29. Hoffmann W, Jagla W, Wiede A (2001) Molecular medicine of TFF-peptides: from gut to brain. Histol Histopathol 16(1):319–334. https://doi.org/10.14670/HH-16.319

    Article  CAS  PubMed  Google Scholar 

  30. Hanisch FG, Bonar D, Schloerer N, Schroten H (2014) Human trefoil factor 2 is a lectin that binds alpha-GlcNAc-capped mucin glycans with antibiotic activity against helicobacter pylori. J Biol Chem 289(40):27363–27375. https://doi.org/10.1074/jbc.M114.597757

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Hoffmann W (2015) TFF2, a MUC6-binding lectin stabilizing the gastric mucus barrier and more. Int J Oncol 47(3):806–816. https://doi.org/10.3892/ijo.2015.3090

    Article  CAS  PubMed  Google Scholar 

  32. Oncology FCG (2014) FIGO staging for carcinoma of the vulva, cervix, and corpus uteri. Int J Gynaecol Obstet 125(2):97–98. https://doi.org/10.1016/j.ijgo.2014.02.003

    Article  Google Scholar 

  33. Yuan CT, Lin MC, Kuo KT, Wang TH, Mao TL (2016) Gastric-type adenocarcinoma in situ of uterine cervix: cytological and histopathological features of two cases. Virchows Arch 469(3):351–356. https://doi.org/10.1007/s00428-016-1978-x

    Article  PubMed  Google Scholar 

  34. Halimi SA, Maeda D, Shinozaki-Ushiku A, Koso T, Matsusaka K, Tanaka M, Arimoto T, Oda K, Kawana K, Yano T, Fujii T, Fukayama M (2013) Claudin-18 overexpression in intestinal-type mucinous borderline tumour of the ovary. Histopathology 63(4):534–544. https://doi.org/10.1111/his.12182

    Article  PubMed  Google Scholar 

  35. Kushima R, Hattori T (1993) Histogenesis and characteristics of gastric-type adenocarcinomas in the stomach. J Cancer Res Clin Oncol 120(1–2):103–111

    Article  CAS  PubMed  Google Scholar 

  36. Fujimori Y, Akamatsu T, Ota H, Katsuyama T (1995) Proliferative markers in gastric carcinoma and organoid differentiation. Hum Pathol 26(7):725–734

    Article  CAS  PubMed  Google Scholar 

  37. Kobayashi M, Fujinaga Y, Ota H (2014) Reappraisal of the Immunophenotype of pancreatic intraductal papillary mucinous neoplasms (IPMNs)-gastric pyloric and small intestinal immunophenotype expression in gastric and intestinal type IPMNs. Acta Histochem Cytochem 47(2):45–57. https://doi.org/10.1267/ahc.13027

    Article  PubMed  PubMed Central  Google Scholar 

  38. Stolnicu S, Barsan I, Hoang L, Patel P, Chiriboga L, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Pike MC, Oliva E, Park KJ, Soslow RA (2018) Diagnostic algorithmic proposal based on comprehensive immunohistochemical evaluation of 297 invasive endocervical adenocarcinomas. Am J Surg Pathol 42(8):989–1000. https://doi.org/10.1097/PAS.0000000000001090

    Article  PubMed  PubMed Central  Google Scholar 

  39. Hanby AM, Poulsom R, Singh S, Elia G, Jeffery RE, Wright NA (1993) Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology 105(4):1110–1116

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Kayo Suzuki and Misako Yamada, research center for supports to advanced science, Shinshu University for providing expert technical assistance, and Dr. Trish Reynolds, MBBS, FRACP, from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript.

Funding

This work was funded by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) for H.O. (26460673).

Author information

Authors and Affiliations

Authors

Contributions

Shiho Asaka: acquisition of data; analysis and interpretation of data; drafting of the manuscript; immunohistochemistry staining. Tomoyuki Nakajima: acquisition of data; analysis and interpretation of data; immunohistochemistry staining. Masanobu Momose: acquisition of data; analysis and interpretation of data; immunohistochemistry staining. Tsutomu Miyamoto: material support; analysis and interpretation of data; critical revision of the manuscript for important intellectual content. Takeshi Uehara: material support; analysis and interpretation of data; critical revision of the manuscript for important intellectual content. Hiroyoshi Ota: acquisition of data; analysis and interpretation of data; drafting of the manuscript; critical revision of the manuscript for important intellectual content; obtaining funding; administrative, technical, or study supervision. All authors contributed to discussions and gave their final approval for the submitted manuscript.

Corresponding author

Correspondence to Hiroyoshi Ota.

Ethics declarations

This study was reviewed and approved by the medical ethics committee of the Shinshu University School of Medicine, Japan (project no. 1875, approved on 6 December, 2011).

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Asaka, S., Nakajima, T., Momose, M. et al. Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix. Virchows Arch 474, 79–86 (2019). https://doi.org/10.1007/s00428-018-2469-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-018-2469-z

Keywords

Navigation